• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Drug Delivery Series I-IV (Oral, Implantable/Injectable, Pulmonary and Transdermal/Transmucosal Systems)

$4,995.00 – $9,990.00

Clear
SKU: KLI1467004 Categories: Drug Delivery Market Reports, Pharmaceuticals Market Research Pages: 475
  • Description
  • Table of Contents
  • Latest reports

Description

Novel pharmacological and biological approaches to disease are calling for novel systems of delivering therapies. This has focused attention on the market for drug delivery systems and the pharmaceuticals that are sold along with those technologies. Kalorama’s Drug Delivery Systems focuses on these technologies.

This offer is for the entire 4 volumes of Kalorama’s 2nd edition of its Drug Delivery Markets series, covering all major types, including:

  • Oral Delivery
  • Implantable/Injectable
  • Pulmonary
  • Transdermal/Transmucosal

While oral delivery remains the most popular and cost-effective methods, implantable and injectable and pulmonary methods are options for fast distribution and stronger dosage. Transdermal patches and new electric transfers allow painless entry for medicines that cannot be administered orally.

Kalorama’s Drug Delivery Markets series provides exhaustive coverage of four key areas of drug delivery.

As part of Kalorama’s trusted information-gathering process, over 70 industry executives in the drug delivery area were interviewed, along with through research of public information, medical journals and company reports. Interviews provide the basis of forecasts.

Table of Contents

Drug Delivery Markets, Vol I: Oral Delivery

Chapter one: Executive Summary

  • Market Drivers
  • Market Size and Growth
    • Total Oral Drug Delivery Market
    • Oral Drug Delivery Technology Only Market
  • Competitive and Market Analysis

Chapter two: Introduction and Overview

  • Scope of the Report
  • Methodology
  • History of Oral Drug Delivery
  • Phases of Drug Action
  • Barriers to Oral Drug Delivery
  • Controlled-Release/Sustained-Release
  • Delayed Release and Modified Release
  • Fast Dissolving
  • Taste-Masked
  • Pulsatile Release
  • Microemulsion and Others

Chapter three: Key Trends and Demographics

  • The Elderly
  • Regulatory Environment
  • Patent Protection and Extension
  • Earlier Involvement
  • Consolidation
  • Proprietary Product Development
  • Implications for Generic and Over-the-Counter Products
  • Pharmaceutical Formulation

Chapter four: New Developments

  • Macromolecule Delivery
  • Delivery of Hydrophobic Drugs
  • Other Delivery Solutions

Chapter five: Market Size and Growth

  • The Total Oral Drug Delivery Market
  • Oral Delivery Technology Only Market

Chapter six: Competitive Analysis

Competitive Landscape

Chapter seven: Company Profiles

  • ALZA Corporation
  • Andrx Pharmaceuticals
  • Biovail Corporation
  • Cardinal Health
  • Elan Corporation, plc
  • Emisphere Technologies, Inc.
  • KV Pharmaceutical
  • Labopharm, Inc.
  • Penwest Pharmaceutical Company
  • Purdue/MundiPharma/Napp Group
  • SkyePharma PLC

Chapter eight: Companies in Brief

  • Alkermes, Inc.
  • Astellas
  • BioProgress Technologies International, Inc.
  • CIMA Labs, Inc. Division of Cephalon
  • DepoMed, Inc.
  • Endorex, Inc.
  • Eurand, Inc.
  • Kos Pharmaceuticals, Inc.
  • Lipocine, Inc.

Appendix: Company Directory

 

List of Exhibits

Chapter one: Executive Summary

Chapter two: Introduction and Overview

  • Table 2-1: Selected Types of Oral Solid Preparations
  • Table 2-2: Sequence of Drug Action

Chapter three: Key Trends and Demographics

  • Table 3-1: World Population by Age Group 2002-2010
  • Figure 3-1: World Population by Age Group 2002-2010
  • Table 3-2: Recent Consolidations in the Drug Delivery Market

Chapter four: New Developments

Chapter five: Market Size and Growth

  • Table 5-1: The Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals Revenues and Growth Rate 2002-2010
  • Figure 5-1: Trending in the Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals 2002-2010
  • Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type 2002-2010
  • Figure 5-2: Trending in the Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type 2002-2010
  • Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Market Share by Type 2002-2010
  • Table 5-4: The Worldwide Market for Oral Drug Delivery Systems by Pharmaceutical vs Drug Delivery Components 2002-2010
  • Table 5-5: The Worldwide Market for Oral Drug Delivery Systems Distribution of Revenue by Pharmaceutical vs Drug Delivery Component 2002-2010
  • Figure 5-3: The Worldwide Market for Oral Drug Delivery Systems Share of Revenue by Pharmaceutical and Drug Delivery Component 2006, 2010

Chapter six: Competitive Analysis

  • Table 6-1: Leading Suppliers of Oral Drug Delivery Technology (Company, Proprietary Technology, Approved Products)

Drug Delivery Markets, 2nd Edition, Vol II: Implantable / Injectable Delivery Systems

Chapter one: Executive Summary

  • Market Drivers
  • Market Size and Growth
    • Total Injectable/Implantable Drug Delivery Market
    • The Injectable/Implantable Drug Delivery Only Market
  • Competitor and Market Analysis

Chapter two: Introduction

  • Scope and Methodology
  • Reasons for Injectable/Implantable Drug Delivery Systems
  • History of Injectable/Implantable Drug Delivery
  • Phases of Drug Action
  • Needle-Free Drug Delivery
    • Major Applications
    • Safety Concerns
    • Products
  • Implantable Drug Delivery
    • Mechanisms
    • Applications
    • Products
  • Sustained-Release Drug Delivery
    • Products
  • Targeted Injection Drug Delivery
    • Products

Chapter three: Trends and Developments

  • Drivers of the Injectable/Implantable Drug Delivery Market
    • Biologics
    • Cancer
  • Pen injectors
  • Proprietary Product Development
  • Delivery Systems Placement Trends
  • Therapeutic Trends
  • Incorporation of Technology
  • Nanotechnology
  • Drug Delivery Development
    • Microsphere Technology
    • Targeted Technology
    • MicroChip Technology
    • NanoParticles
    • Protein-Coated Microcrystal Technology
    • Needle-Free Delivery Development
    • Selected Products in Development

Chapter four: Market Size and Growth

  • The Total Injectable/Implantable Drug Delivery Market
  • Injectable/Implantable Delivery Technology Only Market

chapter five: Competitive and Market Analysis

  • Competitive Landscape
  • Market Analysis

Chapter six: Company Profiles

  • Alkermes, Inc.
  • ALZA Corp.
  • Antares Pharma, Inc.
  • Bioject Medical Technologies, Inc.
  • CyDex, Inc.
  • MGI Pharma, Inc
  • Nektar Therapeutics
  • PowderMed Pharmaceuticals Plc
  • SkyePharma Plc
  • Zogenix Corporation

Chapter seven: Companies in Brief

  • AP Pharma
  • Baxter BioPharma Solutions
  • ImaRx Therapeutics Inc.
  • PR Pharmaceuticals, Inc.
  • pSivida
  • QLT USA, Inc

Appendix: Company Directory

TABLE OF EXHIBITS

Chapter one: Executive Summary

  • Figure 1-1: The Worldwide Market for Injectable/Implantable
  • Drug Delivery Technology and Pharmaceuticals 2002-2010

Chapter two: Introduction

  • Table 2-1: Sequence of Drug Action

Chapter three: Trends and Developments

  • Table 3-1: Select Products in Early Stage Development by Drug
  • Delivery Companies

Chapter four: Market Size and Growth

  • Table 4-1: Worldwide Market for Injectable/Implantable Drug Delivery Technology and Pharmaceuticals 2002-2010
  • Figure 4-1: Worldwide Market for Injectable/Implantable Drug Delivery Technology and Pharmaceuticals 2002-2010
  • Table 4-2: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery by Type 2002-2010
  • Figure 4-2: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery by Type 2002-2010
  • Table 4-3: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2002-2010
  • Figure 4-3: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2006
  • Figure 4-4: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2010
  • Table 4-4: Worldwide Market for Injectable/Implantable Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
  • Table 4-5: Injectable/Implantable Drug Delivery Systems: Worldwide Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
  • Figure 4-5: Injectable/Implantable Drug Delivery Systems Worldwide Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
  • Figure 4-6: Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010

chapter five: Competitive and Market Analysis

  • Table 5-1: Leading Suppliers of Injectable/Implantable Drug Delivery Technology
  • Figure 5-1: Cost per Million Injections by Injector Type

Drug Delivery Markets, Vol III: Pulmonary Delivery Systems

Chapter one: Executive Summary

  • Market Drivers
  • Market Size and Growth
  • The Total Pulmonary Drug Delivery Market
  • The Total Pulmonary Drug Delivery Only Market
  • Competitor and Market Analysis

Chapter two: Introduction and Overview

  • Scope and Methodology
  • Reasons for pulmonary Drug Delivery Systems
  • History and Mechanics of Pulmonary Drug Delivery
  • Phases of Drug Action
  • Pharmacokinetics of Inhalation
  • Inhalation Delivery Technologies
  • Metered Dose Inhalers
  • Dry Powder Formulations
  • Nebulizer Delivery Formulations
  • Liquid Formulations
  • Nanospheres
  • Intranasal Delivery Technologies

Chapter three: Trends and Demographics

  • Asthma
  • Opportunities for Drug Delivery System Success
  • Exubera Breakthrough
  • Nano and Microparticulate Systems
  • Trends in Liquid Aerosols
  • CFC Phase Out
  • Expansion of Biotechnology
  • Macromolecule Delivery

Chapter four: New Developments

  • Prodrug Drug Delivery
  • Electrohydrodynamic Aerosol Delivery
  • Oxygen Delivery
  • Crystallization Technology

Chapter five: Market Size and Growth

  • The Total Pulmonary Drug Delivery Market
  • Pulmonary Delivery Technology Only Market

Chapter six: Competitive and Market Analysis

  • Competitor Analysis
  • Market Analysis

Chapter seven: Company Profiles

  • 3M Pharmaceuticals
  • Alkermes, Inc.
  • Aradigm Corporation
  • Elan Corporation, Plc
  • Innovata BioMed Plc
  • MicroDose Technology, Inc
  • Nastech Pharmaceutical Company Inc.
  • Nektar Therapeutics
  • Oriel Therapeutics
  • Pipex Pharmaceuticals
  • Resiprics, Inc.
  • SkyePharma Plc
  • Vectura Ltd.
  • Ventaira Pharmaceuticals, Inc.

Chapter eight: Companies in Brief

  • Bespak
  • Direct Haler A/S
  • IntraNasal Therapeutics

Appendix: Company Directory

TAble of exhibits

Chapter one: Executive Summary

  • Table 1-1: The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
  • Figure 1-1: The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
  • Table 1-2: The Worldwide Market for Pulmonary Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
  • Figure 1-2: The Worldwide Market for Pulmonary Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010

Chapter two: Introduction and Overview

  • Table 2-1: Sequence of Drug Action

Chapter three: Trends and Demographics

  • Table 3-1: Worldwide Prevalence of Asthma 2006
  • Figure 3-1: Worldwide Prevalence of Asthma 2006
  • Table 3-2: World Population by Age Group 2002-2010
  • Figure 3-2: World Population by Age Group 2002-2010

Chapter fivE: Market Size and Growth

  • Table 5-1: The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
  • Figure 5-1: The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
  • Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Systems by Type 2002-2010
  • Figure 5-2: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Systems Revenues by Type 2002-2010
  • Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Technologies Market Share by Type 2002-2010
  • Figure 5-3: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Technologies by Type 2006
  • Figure 5-4: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Technologies by Type 2010
  • Table 5-4: The Worldwide Market for Pulmonary Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
  • Table 5-5 of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
  • Figure 5-5 of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
  • Figure 5-6: The Worldwide Market for Pulmonary Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
  • Figure 5-7: The Worldwide Market for Pulmonary Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010

Chapter six: Competitive and Market Analysis

  • Table 6-1: Selected Leading and Emerging Suppliers of Pulmonary Drug
  • Delivery Technology

Drug Delivery Markets, Vol. IV: Transdermal

Chapter One: Executive Summary

  • Market Drivers
  • Market Size and Growth
    • Total Transdermal/Transmucosal Drug Delivery Market
    • Transdermal/Transmucosal Drug Delivery Only Market
    • Competitive and Market Analysis

Chapter Two: Introduction and Overview

  • Scope and Methodology
  • Reasons for Transdermal/Transmucosal Drug Delivery Systems
  • History of Transdermal and Transmucosal Drug Delivery
  • Phases of Drug Action
  • Topical Drug Delivery
    • Types of Topical Preparations
    • Market Participants
    • Transdermal Patch Drug Delivery
      • Membrane-Controlled System
      • Adhesive Dispersion-Type System
      • Matrix Diffusion-Controlled System
      • Microreservoir Dissolution-Controlled System
      • New Transdermal Drug Applications and Approvals
      • Electrotransport Drug Delivery
      • Iontophoresis
      • Transmucosal Drug Delivery
        • Oral Transmucosal Fentanyl Citrate (OTFC)
        • Transmucosal Etomidate
        • Ondansetron ODT
        • Buccal Drug Delivery
        • Vaginal Drug Delivery

Chapter three: Trends and Developments

  • Innovations in Transdermal Drug Delivery
  • Adhesive Technology and Issues
  • Adhesive Market Issues
  • Biotechnological Issues
  • Iontophoresis and Sonophoresis
  • Developments in Insulin Delivery
  • New Developments in Hormone Drug Delivery
  • New Mucosal/Buccal Delivery Systems
  • Other New Drug Delivery Systems
  • Macroflux Technology
  • Controlled Thermal Energy Technology
  • New Ultrasound Technology
  • Combination Delivery Technology
  • Transdermal Products in Development

Chapter four: Market Size and Growth

  • The Total Transdermal/Transmucosal Drug Delivery Market
  • Transdermal/Transmucosal Delivery Technology Only Market

chapter five: Competitive Analysis

  • Competitive Landscape
  • Market Analysis

CHAPTER SIX: Company Profiles

  • 3M Pharmaceuticals
  • Acrux Limited
  • Altea Therapeutics, Inc
  • ALZA Corporation
  • Antares Pharma, Inc.
  • Aveva Drug Delivery Systems
  • Cardinal Health
  • Cephalon Inc
  • Generex Biotechnology Corporation
  • Inovio Biomedical Corporation
  • Labtec GmbH
  • Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)…………….
  • MacroChem Corporation
  • NexMed, Inc.
  • Noven Pharmaceuticals, Inc.
  • SkyePharma PLC

Appendix

Company Directory

Table of exhibits

chapter twO: Introduction and Overview

  • Table 2-1: Sequence of Drug Action

Chapter three: Trends and Developments

  • Table 3-1: Selected Transdermal Products in Development

Chapter four: Market Size and Growth

  • Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals 2002-2010
  • Figure 4-1.. : The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals 2002-2010
  • Table 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Systems by Type 2002-2010
  • Figure 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Systems Revenues by Type 2002-2010
  • Table 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Technologies Market Share by Type 2002-2010…….
  • Figure 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Technologies by Type 2006
  • Figure 4-4: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Technologies by Type 2010
  • Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
  • Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
  • Figure 4-5.. : The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
  • Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
  • Figure 4-7: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010

chapter five: Competitive Analysis

  • Table 5-1: Leading Suppliers of Transdermal/Transmucosal Drug Delivery Technology

 

    The Market for Needle-Free Drug Delivery Systems
    July 14, 2016
    Transdermal and Transmucosal Drug Delivery Markets: Forecasts to 2020
    November 25, 2015
    The World Market for Implantable and Needle-Free Drug Delivery Systems
    December 11, 2013
    The World Market for Transdermal Drug Delivery
    September 13, 2012

Related products

  • Placeholder image

    Market for Rx-to-OTC Switches, 3rd Edition, The

    $2,625.00 – $5,250.00
  • Placeholder image

    Type II Diabetes: The 45 Market in the United States for Drugs and Diagnostics

    $2,995.00 – $5,990.00
  • Placeholder image

    Growth Factors: Indications, Products, and Markets

    $2,625.00 – $5,250.00
  • Placeholder image

    Advanced Drug Delivery: Technologies, Applications, and Markets

    $2,625.00 – $5,250.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Anti Infectives: World Market, 2nd Edition, Vol II: AntibacterialsMedical Imaging Markets, Volume V – Molecular Imaging
Scroll to top